๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Dendritic cell-based cancer immunotherapy

โœ Scribed by Edgar G Engleman

Book ID
114106620
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
222 KB
Volume
30
Category
Article
ISSN
0093-7754

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Monitoring of circulating angiogenic fac
Monitoring of circulating angiogenic factors in dendritic cellโ€“based cancer immunotherapy
โœ Christine Brostjan; Anita Bayer; Anna Zommer; Alexander Gornikiewicz; Sebastian ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 147 KB

## Abstract ## BACKGROUND A promising treatment approach for patients with malignant disease that recently has found its way into clinical trials is based on vaccination with autologous dendritic cells loaded with tumor antigens. However, adequate assays for monitoring clinical and immunologic res

From pathogen to medicine: HIV-1-derived
From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy
โœ Melissa Dullaers; Kris Thielemans ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 272 KB

Over the years, the unique capacity of dendritic cells (DC) for efficient activation of naive T cells has led to their extensive use in cancer immunotherapy protocols. In order to be able to fulfil their role as antigen-presenting cells, the antigen of interest needs to be efficiently introduced and